Drug Shortage Report for ANANDRON
Report ID | 13478 |
Drug Identification Number | 02221861 |
Brand name | ANANDRON |
Common or Proper name | Nilutamide |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | DORMANT |
Active Ingredient(s) | NILUTAMIDE |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 90 |
ATC code | L02BB |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2017-06-20 |
Actual start date | 2017-06-20 |
Estimated end date | 2017-06-26 |
Actual end date | 2017-06-29 |
Shortage status | Resolved |
Updated date | 2017-07-06 |
Company comments | Production delay - : Anandron tablets is currently on temporary BO but product may be available at some distribution centers |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-07-06 | French | Compare |
v4 | 2017-07-06 | English | Compare |
v3 | 2017-06-21 | French | Compare |
v2 | 2017-06-21 | French | Compare |
v1 | 2017-06-21 | English | Compare |
Showing 1 to 5 of 5